Drug development for all: How we believe Open Science can help develop treatments for those left behind
Health is core to our quality of life, yet millions worldwide lack treatments to diseases that threaten their lives or quality of life. For example, an estimated 400 million people worldwide live with a rare disease, 95% of which do not have a single treatment. Half of those individuals are children. Alzheimer’s disease and other […]
CACHE Challenge #3 identifies four ‘hits’ for potential coronavirus treatment
In our third CACHE Challenge, researchers from across the globe used computational methods to predict molecules to bind on a potential target to develop medicines against SARS-CoV-2. The four top-performing teams identified four molecules that were chemically novel and showed promise as starting points for drug development. For more information, contact:Estrid Jakobsen at [email protected] Preeti Singh […]
AstraZeneca joins CACHE Governing Board
We are pleased to announce that AstraZeneca, a global, science-led biopharmaceutical company has joined the CACHE (Critical Assessment of Computational Hit-finding Experiments) Governing Board for a two-year term, which is a critical element of Conscience’s efforts to set clear industry-leading benchmarks and improve success rates in the current drug discovery system. Bringing a wealth of […]
The 2024 Nobel Prizes in Chemistry and Physics recognize advances in fields crucial to drug discovery
The Royal Swedish Academy of Sciences on Wednesday announced the 2024 Nobel Prizes, two of which represent significant advances in scientific fields that are crucial to drug discovery and Conscience’s mission. These discoveries, which relied on high-quality, open data, exemplify the importance of both quality and openness of data for the future of AI in […]
Forbes features top-scoring CACHE 2 team and highlights importance of participation from the Global South
How Can AI Help Discover ‘New’ Drugs Against COVID-19 In Brazil? Read the full article in Forbes »
Chemical & Engineering News features Conscience and top CACHE 2 participants
Open-source competition finds potential coronavirus drugs Read the full article on Chemical & Engineering News »
Get to Know Our Partnerships Lead, Lauriane
We are excited to share a new podcast episode featuring Lauriane Gorce, Conscience’s Partnerships Lead, on Papa PhD, which aims to help students thrive beyond academia. Lauriane met David at a networking event and joined the podcast to share her journey and insights on finding a fulfilling career that balances societal impact, work, and personal […]
KBIA news features CACHE 2 participant Dmitri Kireev and Conscience CEO Ryan Merkley
MU researcher’s AI model advances coronavirus drug development Read the full article on KBIA News »
The Logic features top-scoring CACHE 2 team and Conscience CEO Ryan Merkley
The global contest, run by Toronto’s Conscience, hunting for the best AI tools to find new medicines Read the full article on The Logic »
CACHE Challenge #2 identifies seven ‘hits’ for pan-coronavirus treatment
In our second CACHE Challenge, researchers from across the globe identified seven promising early-stage molecules that could lead to a new treatment effective against all coronaviruses, advancing preparedness for future pandemic threats. For more information, contact:Estrid Jakobsen at [email protected] Preeti Singh at [email protected] Conscience Announces Top Performers in Open Science Challenge to Design Promising Pan-Coronavirus Drugs […]
Upcoming Request for Proposals: Developing Medicines through Open Science
We are excited to announce Conscience’s upcoming Request for Proposals for the Developing Medicines through Open Science program! This initiative is designed to foster collaborative drug discovery and development in areas often overlooked by the pharmaceutical industry, such as orphan diseases and antimicrobial resistance. The inaugural round of this program will offer a total of […]
